Delivery Order SPE2DB22D1041-SPE2DB25FUBR4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Rabavert rabies vaccine with diluents. This firm fixed price delivery order, valued at $2,840.90, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by August 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,910.10 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 21, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award is issued as a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,895.45 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. This award falls under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,257.48 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the federal government's medical supply needs through AmerisourceBergen's established vendor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,297.80 firm fixed price delivery order for Rabavert rabies vaccine with diluents, effective August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $27,582.69 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed price contract type. This delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and performance will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,931.26 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies performance in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order operates as a child contract under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,348.49 to AmerisourceBergen Drug Corp for the supply of Rabavert Rabies Vaccine with diluents. This firm fixed-price contract, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation. Performance will be...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Rabavert rabies vaccine with diluents. This is a firm fixed price delivery order valued at $1,047.90 with a completion date of September 23, 2025. The contract carries no set-aside designation and was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,226.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of August 12, 2025. The award was made on August 11, 2025, with no set-aside designation, and performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUBR4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,257.48 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, issued September 2, 2025, with completion targeted for September 23, 2025, represents a firm fixed-price procurement with no set-aside designation. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical supply arrangement supporting the DLA's Medical Supply Chain, which provides critical medical commodities to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The rabies vaccine delivery exemplifies the company's role in supplying vaccines and specialized medical products across multiple therapeutic domains under the broader Pharmaceutical Prime Vendor Global Program framework. AmerisourceBergen's ability to secure this competitively awarded contract demonstrates its continued capability to meet federal procurement requirements for time-sensitive medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/2/25 |